KCM
DRTX

Kanawha Capital Management’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Kanawha Capital Management’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-13,000
Closed -$221K – 160
2014
Q2 		$221K Hold
13,000
– – 0.04% 151
2014
Q1 		$175K Buy
13,000
+2,000
+18% +$26.2K 0.03% 151
2013
Q4 		$141K Hold
11,000
– – 0.03% 150
2013
Q3 		$99K Buy
+11,000
New +$91.2K 0.02% 144

Other funds holding DRTX

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Kanawha Capital Management's DRTX Position: Q3 2014 in Review

Kanawha Capital Management sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q3 2014, closing a stake of 13,000 shares — an estimated $221K sold.

Kanawha Capital Management first reported a position in DRTX in Q3 2013 and held it in 4 quarters. The position peaked at $221K in Q2 2014. 70 funds tracked by Wall St. Rank hold DRTX as of Q3 2014.

  • Kanawha Capital Management reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Kanawha Capital Management sold 13,000 DURATA THERAPEUTICS INC COM STK (DE) shares in Q3 2014, an estimated $221K.
  • Kanawha Capital Management first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q3 2013 and held it in 4 quarters.
  • Kanawha Capital Management's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $221K in Q2 2014.
  • 70 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q3 2014.

Based on Kanawha Capital Management's 13F filing for Q3 2014, filed 30 Oct 2014.